FDA approved Semaglutide injection for chronic weight management in adults with obesity or overweight, along with at least one weight-related ailment such as high blood pressure, type 2 diabetes, or high cholesterol
Some participants achieved even more dramatic results, with weight loss exceeding 30% of starting weight
Another key point to consider is that heart palpitations can happen for many reasons unrelated to semaglutide
For Novo Nordisk, the company expects its sales growth this year of 32% to 38%
Approved in 2017 to treat tardive dyskinesia, Ingrezza is a selective vesicular monoamine transporter 2 inhibitor
If you experience these symptoms, check your glucose if possible and consume 15-20 grams of fast-acting carbohydrate